| BMS707035 |
|
| (CAS 729607-74-3) |
 |
| Description： |
BMS-707035 is an HIV-1 integrase (IN) inhibitor with an IC50 value of 15 nM.
BMS-707035 was scheduled to be evaluated in a Phase II study to assess the antiretroviral activity, safety, pharmacodynamics, and pharmacokinetics in 50 HIV-infected subjects using a 10-day randomized, double-blind, placebo-controlled, ascending multiple-dose study design.
|
| Product No. |
KT00207 |
| Product Name |
BMS707035 |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
729607-74-3 |
| Molecular Formula |
C17H19FN4O5S |
| Formula Weight |
410.42 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Abacavir
AMD 3465
Amprenavir
Atazanavir
Bevirimat
BMS-378806
BMS-538203
BMS-626529
BMS-663068
|
|
